Chronic low-grade inflammation and pro-inflammatory cytokines, such as TNF-α and IL-6 as well as others, contribute to the development of glucose intolerance and insulin resistance-related metabolic syndrome and T2D [19]–[21], [24]. The gene discussed is IL6; the disease is metabolic syndrome.